INO — Inovio Pharmaceuticals Share News
0.000.00%
- $92.76m
- $56.08m
- $0.07m
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Q2 net loss narrows on warrant gain, lower costs
Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million
Inovio Pharmaceuticals Inc expected to post a loss of 22 cents a share - Earnings Preview
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
U.S. STOCKS ON THE MOVE-Mastercard, Starbucks, Meta
U.S. STOCKS ON THE MOVE-Avery Dennison, Huntington Ingalls, XPO
U.S. STOCKS ON THE MOVE-Fortinet, Regeneron, Cigna
Inovio Pharma plummets on stock-and-warrants sale
Brief: INOVIO Announces Pricing Of $20.0 Million Public Offering
Brief: Inovio Announces Proposed Public Offering
Inovio Pharma plunges on planned equity offering
Brief: Inovio Reports First Quarter 2026 Financial Results And Recent Business Highlights
Inovio Pharmaceuticals posts flat Q1 net loss
Moderna climbs for second straight session
Moderna climbs for second straight session
Moderna set to climb for second straight session